MA06.07 Inferior Outcomes in Minority Patients with Unresectable Non-Small Cell Lung Cancer (NSCLC) After Durvalumab Consolidation Therapy

Autor:	F. Dickson, Luis E. Raez, D. Walker, H. Powery, K. Dumais
Rok vydání:	2021
Předmět:	Pulmonary and Respiratory Medicine Oncology Consolidation therapy medicine.medical_specialty Durvalumab business.industry Internal medicine medicine non-small cell lung cancer (NSCLC) medicine.disease business
Zdroj:	Journal of Thoracic Oncology. 16:S904-S905
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2021.08.139
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fbe2f88de07196afcf1f0bea93997bb9 https://doi.org/10.1016/j.jtho.2021.08.139 Zobrazit plný text záznamu